FREE Case Evaluation: 1-888-887-3117
The latest hair relaxer MDL update shows this litigation is one of the fastest-growing mass tort cases in the U.S. Here is a quick snapshot:
| Key Detail | Current Status |
|---|---|
| Active federal lawsuits | Over 11,105 (as of February 2026) |
| MDL number | MDL No. 3060 |
| Presiding judge | Judge Mary Rowland |
| Court location | Northern District of Illinois |
| Bellwether discovery pool | 32 selected cases |
| Science Day | January 8, 2026 |
| Expected first trial | 2027 |
| Settlement mediator | Special Master Ellen K. Reisman (appointed April 2025) |
More than 11,000 women have filed lawsuits claiming that chemical hair relaxers caused serious cancers, including uterine, ovarian, and endometrial cancer. The litigation is centralized in Chicago under MDL No. 3060 and is now deep into the discovery phase, with bellwether trial preparation actively underway.
If you used chemical hair relaxers and were later diagnosed with cancer or uterine fibroids, you may have legal options — and the window to file is still open.
I'm Tim Burd, CEO of Justice Hero, a legal services company that connects individuals harmed by defective products with the right law firms. My team tracks every major development in the hair relaxer MDL update so you have the clearest, most current picture of where this litigation stands. Read on for a full breakdown of what is happening and what it means for your potential claim.
Hair relaxer MDL update vocabulary:
As we move through 2026, the sheer scale of the hair relaxer litigation has become impossible to ignore. What started as a handful of individual cases in early 2023 has exploded into a massive federal multidistrict litigation (MDL). As of February 10, 2026, there are over 11,105 active lawsuits in the Hair Relaxer MDL.
This growth represents a steady climb from earlier milestones. For instance, the 10,552 active hair relaxer cancer lawsuits in the group litigation reported in October 2025 showed that the pace of new filings remains significant, even as the litigation matures. The centralization in the Northern District of Illinois under Judge Mary Rowland has allowed the court to handle these thousands of claims efficiently, ensuring that individual plaintiffs aren't lost in the shuffle of different state courts.
To help streamline this process, the court uses "short-form complaints." These allow new plaintiffs to join the MDL quickly by checking off the specific products they used and the injuries they suffered. If you are looking for a comprehensive breakdown of how these filings work, our hair-relaxer-lawsuit-guide-2025 provides the necessary roadmap. While the filing pace has leveled off from the initial surge of 2,000 to 3,000 cases per month seen in mid-2023, the steady addition of over 100 cases monthly shows that more women are becoming aware of the potential link between their health struggles and the products they used for decades.
We are currently in a "defining phase" of the litigation. The discovery phase—where both sides exchange documents and take depositions—is in full swing. This is the "nitty-gritty" part of the law where we find out what the manufacturers knew and when they knew it.
A critical part of this phase involves Plaintiff Fact Sheets (PFS). These are detailed documents where plaintiffs provide their medical history and product usage details. It is vital for anyone in the MDL to ensure their PFS is accurate and complete; otherwise, they risk having their case dismissed. For a deeper look at what evidence is required, you can consult our hair-straightener-lawsuits-complete-guide.
One of the most important dates on the recent calendar was January 8, 2026—Science Day. In complex mass torts like this, Science Day is a non-adversarial presentation where experts teach the judge about the underlying science of the case.
The focus was on how A 2022 study by the National Institutes of Health (NIH) and other research link endocrine-disrupting chemicals (EDCs) to reproductive cancers. We aren't just talking about lye; we are looking at phthalates (like DEHP), parabens, and formaldehyde. These chemicals can be absorbed through the scalp, especially when the products cause burns or irritation. For those interested in the specific link between these toxins and health outcomes, our page on chemical-straightener-cancer explains the biological mechanisms at play.
The court has selected a "discovery pool" of 32 cases to serve as the first wave of test trials, known as bellwethers. These cases are split between the two sides, with 16 selected by plaintiffs and 16 by defendants. They represent the most common injuries cited in the litigation:
The purpose of these trials is to see how a jury reacts to the evidence. While the first trial is currently expected in early 2027, these dates are pivotal because they create immense pressure on defendants to consider a settlement. You can learn more about the specific types of cancer involved in our relaxer-cancer-lawsuit overview.
The court has been busy managing the logistical hurdles of a case this large. One of the most significant moves was the appointment of Special Master Ellen K. Reisman in April 2025. Her role is to oversee settlement negotiations and help the parties reach a resolution without needing to try all 11,000+ cases individually.
Settlement discussions often hinge on "points-based systems," where the payout is determined by the severity of the injury, the duration of product use, and the age of the plaintiff. We provide more detail on these potential structures in our guide on hair-relaxer-settlement-and-payouts.
A major victory for plaintiffs came out of Georgia. The Georgia Supreme Court recently ruled on a "statute of repose" issue in the Kiara Burroughs case. Essentially, the defendants argued that if a woman first used a relaxer more than 10 years ago, she couldn't sue. However, the court ruled that because the exposure was repeated and ongoing, the clock didn't start until the most recent use. This is a massive win for women who used these products for 20, 30, or 40 years. For more on the health risks associated with long-term use, check out straight-talk-could-your-hair-straightener-be-linked-to-breast-cancer.
Not everything has been smooth sailing. There have been significant discovery disputes, particularly involving Revlon and L’Oréal. Revlon’s bankruptcy initially complicated matters, but the court has allowed discovery to proceed against them.
Plaintiffs' attorneys are pushing hard for internal marketing documents and safety data that might show the companies knew about the risks of phthalates but continued to market the products aggressively to Black and Brown women. If you are looking for legal representation to navigate these complex disputes, finding a qualified hair-straightener-lawsuit-lawyer is the first step.
Qualifying for a claim depends on several factors, primarily your medical diagnosis and your history of using these products. While the focus has been heavily on cancer, many women are also filing claims for uterine fibroids that resulted in major surgery.
| Injury Category | Key Eligibility Criteria |
|---|---|
| Uterine Cancer | Diagnosis of endometrial cancer or uterine sarcoma after regular use (4+ times/year). |
| Ovarian Cancer | Diagnosis of ovarian cancer with a history of long-term relaxer usage. |
| Endometrial Cancer | Specifically cited in the study published in the Journal of the National Cancer Institute. |
| Uterine Fibroids | Must have resulted in a surgical intervention, such as a hysterectomy or myomectomy. |
To strengthen your case, you will need to gather medical records and, if possible, evidence of the brands you used (receipts, containers, or salon records). If you believe you qualify, you can start the process by filling out our hair-relaxer-contact-form.
The litigation targets the major players in the hair care industry. The most common brands and manufacturers named include:
These companies are alleged to have sold products containing toxic chemicals without providing adequate warnings to consumers.
It is important to remember that no settlements have been reached yet, so any numbers are projections based on similar mass torts. Legal experts suggest a range of $150,000 to $750,000 for strong cancer cases. Cases involving uterine fibroids or less severe injuries may see lower amounts. The final payout will likely depend on a points-based system that considers the severity of the illness and the impact on the victim's life.
This depends on the "statute of limitations" in your specific state. Generally, the clock starts ticking from the moment you were diagnosed or the moment you realized the product caused your injury (the "discovery rule"). Because these deadlines vary wildly and can be as short as one or two years, it is critical to consult with a lawyer immediately to ensure you don't lose your right to seek compensation.
The hair relaxer MDL update for 2026 shows a litigation that is moving steadily toward its first day in court. With over 11,000 women standing together, the pressure on manufacturers like L’Oréal and Revlon is mounting. While we wait for the 2027 trial window, the work being done now in discovery and settlement mediation will define the future of these claims.
At Justice Hero, we believe in corporate accountability. No one should have to trade their health for a beauty product. If you have been affected, we are here to help you navigate the path to justice. Stay informed and take action by visiting our main hair-relaxer-lawsuit page for the latest news and resources.
